289 related articles for article (PubMed ID: 1696547)
61. Epidermal growth factor (EGF) promotes phosphorylation at threonine-654 of the EGF receptor: possible role of protein kinase C in homologous regulation of the EGF receptor.
Whiteley B; Glaser L
J Cell Biol; 1986 Oct; 103(4):1355-62. PubMed ID: 3021781
[TBL] [Abstract][Full Text] [Related]
62. Importance of tyrosine phosphatases in the effects of cell-cell contact and microenvironments on EGF-stimulated tyrosine phosphorylation.
Mansbridge JN; Knüchel R; Knapp AM; Sutherland RM
J Cell Physiol; 1992 Jun; 151(3):433-42. PubMed ID: 1284249
[TBL] [Abstract][Full Text] [Related]
63. Intensification of growth factor receptor signalling by phorbol treatment of ligand-primed cells implies a dimer-stabilizing effect of protein kinase C-dependent juxtamembrane domain phosphorylation.
Gulliford T; Ouyang X; Epstein RJ
Cell Signal; 1999 Apr; 11(4):245-52. PubMed ID: 10372802
[TBL] [Abstract][Full Text] [Related]
64. Epidermal growth factor stimulates phosphorylation of eukaryotic initiation factor 4B, independently of protein kinase C.
Wolthuis RM; Cremers AF; Kasperaitis MA; van der Mast C; Voorma HO; Boonstra J
Biochim Biophys Acta; 1993 Jun; 1177(2):160-6. PubMed ID: 8388736
[TBL] [Abstract][Full Text] [Related]
65. Ligand-induced activation of epidermal growth factor receptor in intact rat mammary adenocarcinoma cells without detectable receptor phosphorylation.
Lichtner RB; Wiedemuth M; Kittmann A; Ullrich A; Schirrmacher V; Khazaie K
J Biol Chem; 1992 Jun; 267(17):11872-80. PubMed ID: 1318304
[TBL] [Abstract][Full Text] [Related]
66. c-Src phosphorylates epidermal growth factor receptor on tyrosine 845.
Sato K; Sato A; Aoto M; Fukami Y
Biochem Biophys Res Commun; 1995 Oct; 215(3):1078-87. PubMed ID: 7488034
[TBL] [Abstract][Full Text] [Related]
67. Inhibitory effects of alpha-interferon on epidermal growth factor-mediated receptor-dependent events.
Fish EN; Ghislain J; Trogadis J; Stevens JK
Cancer Res; 1993 Nov; 53(21):5148-57. PubMed ID: 7693332
[TBL] [Abstract][Full Text] [Related]
68. Inhibition of epidermal growth factor-induced phosphorylation by trifluoperazine.
Ross AH; Damsky C; Phillips PD; Hwang F; Vance P
J Cell Physiol; 1985 Sep; 124(3):499-506. PubMed ID: 2413056
[TBL] [Abstract][Full Text] [Related]
69. Structural aspects of the epidermal growth factor receptor required for transmodulation of erbB-2/neu.
Worthylake R; Wiley HS
J Biol Chem; 1997 Mar; 272(13):8594-601. PubMed ID: 9079690
[TBL] [Abstract][Full Text] [Related]
70. Augmented desensitization to epidermal growth factor (EGF) immediate actions: a novel mechanism for altered EGF growth response in mutant A431 cells.
Karasik A; Reddy SS; Pepinsky RB; Brock T; Kahn CR
J Cell Physiol; 1990 Feb; 142(2):231-5. PubMed ID: 1689316
[TBL] [Abstract][Full Text] [Related]
71. Membrane vesicles of A431 cells contain one class of epidermal growth factor binding sites.
Berkers JA; van Bergen en Henegouwen PM; Verkleij AJ; Boonstra J
Biochim Biophys Acta; 1990 May; 1052(3):453-60. PubMed ID: 2354208
[TBL] [Abstract][Full Text] [Related]
72. Effect of epidermal growth factor on cadherin-mediated adhesion in a human oesophageal cancer cell line.
Shiozaki H; Kadowaki T; Doki Y; Inoue M; Tamura S; Oka H; Iwazawa T; Matsui S; Shimaya K; Takeichi M
Br J Cancer; 1995 Feb; 71(2):250-8. PubMed ID: 7530982
[TBL] [Abstract][Full Text] [Related]
73. Wound-induced HB-EGF ectodomain shedding and EGFR activation in corneal epithelial cells.
Xu KP; Ding Y; Ling J; Dong Z; Yu FS
Invest Ophthalmol Vis Sci; 2004 Mar; 45(3):813-20. PubMed ID: 14985295
[TBL] [Abstract][Full Text] [Related]
74. Signaling-inactive epidermal growth factor receptor/ligand complexes in intact carcinoma cells by quinazoline tyrosine kinase inhibitors.
Lichtner RB; Menrad A; Sommer A; Klar U; Schneider MR
Cancer Res; 2001 Aug; 61(15):5790-5. PubMed ID: 11479217
[TBL] [Abstract][Full Text] [Related]
75. Suppression of extracellular signals and cell proliferation by the black tea polyphenol, theaflavin-3,3'-digallate.
Liang YC; Chen YC; Lin YL; Lin-Shiau SY; Ho CT; Lin JK
Carcinogenesis; 1999 Apr; 20(4):733-6. PubMed ID: 10223207
[TBL] [Abstract][Full Text] [Related]
76. Monoclonal anti-epidermal growth factor receptor antibodies which are inhibitors of epidermal growth factor binding and antagonists of epidermal growth factor binding and antagonists of epidermal growth factor-stimulated tyrosine protein kinase activity.
Gill GN; Kawamoto T; Cochet C; Le A; Sato JD; Masui H; McLeod C; Mendelsohn J
J Biol Chem; 1984 Jun; 259(12):7755-60. PubMed ID: 6330079
[TBL] [Abstract][Full Text] [Related]
77. Protein-tyrosine-phosphatase-mediated epidermal growth factor (EGF) receptor transinactivation and EGF receptor-independent stimulation of mitogen-activated protein kinase by bradykinin in A431 cells.
Graness A; Hanke S; Boehmer FD; Presek P; Liebmann C
Biochem J; 2000 Apr; 347(Pt 2):441-7. PubMed ID: 10749673
[TBL] [Abstract][Full Text] [Related]
78. Biochemical characterization of mutant EGF receptors expressed in the hemopoietic cell line BaF/3.
Walker F; Hibbs ML; Zhang HH; Gonez LJ; Burgess AW
Growth Factors; 1998; 16(1):53-67. PubMed ID: 9777370
[TBL] [Abstract][Full Text] [Related]
79. Epidermal growth factor stimulates the tyrosine phosphorylation of SHC in the mouse.
Ruff-Jamison S; McGlade J; Pawson T; Chen K; Cohen S
J Biol Chem; 1993 Apr; 268(11):7610-2. PubMed ID: 7681824
[TBL] [Abstract][Full Text] [Related]
80. The oncogenic ErbB-2/ErbB-3 heterodimer is a surrogate receptor of the epidermal growth factor and betacellulin.
Pinkas-Kramarski R; Lenferink AE; Bacus SS; Lyass L; van de Poll ML; Klapper LN; Tzahar E; Sela M; van Zoelen EJ; Yarden Y
Oncogene; 1998 Mar; 16(10):1249-58. PubMed ID: 9546426
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
